You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IRD Sale Disclosure
Gagnon Robert E. · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$127.21K
Gagnon Robert E. Chief Financial Officer
IRD
Opus Genetics
IRD
Transaction date
Sep 3, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 5 days later
IRD daily price context
Close on/before transaction
$4.6
Sep 3, 2026
First close after public filing
$5.73
Sep 9, 2026
30-day return after filing
-22.16%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 28,000 shares @ $4.54
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-035912
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$127.21K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Opus Genetics, Inc. IRD Current | Sale | Sep 3, 2026 | $127.21K |